Crossmark

Efficacy of sintilimab combined with neoadjuvant chemotherapy and trastuzumab in conversional treatment of locally advanced HER2-positive gastric cancer: case analysis and literature review

Crossref DOI link: https://doi.org/10.1007/s00432-024-06024-6

Published Online: 2024-11-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ibrahim, Sidikjan

Maimaitiaili, Amina

Zhu, Guangsheng

Ye, Shengwei
License Information

Text and Data Mining valid from 2024-11-19

Version of Record valid from 2024-11-19
More Information

Article History

Received: 11 June 2024

Accepted: 1 November 2024

First Online: 19 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below